Cite
HARVARD Citation
Falkenberg, N. et al. (n.d.). Additive impact of HER2‐/PTK6‐RNAi on interactions with HER3 or IGF‐1R leads to reduced breast cancer progression in vivo. Molecular oncology. 9 (1), pp. 282-294. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Falkenberg, N. et al. (n.d.). Additive impact of HER2‐/PTK6‐RNAi on interactions with HER3 or IGF‐1R leads to reduced breast cancer progression in vivo. Molecular oncology. 9 (1), pp. 282-294. [Online].